Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgin A6 family-like 9 pseudogene, abbreviated as GOLGA6L9P or GOLGA6L9, is a human pseudogene classified as a processed pseudogene based on sequence similarity to members of the Golgin A6 family of proteins[3][10][11]. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional; they arise from duplication or retrotransposition events and contain disabling mutations that prevent the expression of functional proteins[2][4][8]. According to both Genecards and HGNC, ENSG00000259683 is annotated as a pseudogene, not a protein-coding gene[3][10]. There is no established biological function, disease association, or therapeutic targeting, and the sequence does not serve as a known biomarker or interact with drugs[10][11]. While some pseudogenes may be transcribed or have regulatory impacts, this has not been reported for Golgin A6 family-like 9 pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin A6 family-like 9 pseudogene (GOLGA6L9P).